Nautilus Biotechnology, Inc. Basic Shares Outstanding (Weighted Average)
Nautilus Biotechnology, Inc. (NAUT) reported Basic Shares Outstanding (Weighted Average) of 127.14 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-07-28
- Nautilus Biotechnology, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 127.14M shares, a 0.74% increase year-over-year.
- Nautilus Biotechnology, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 126.63M shares, a 0.39% increase year-over-year.
- Nautilus Biotechnology, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 126.37M shares, a 0.45% increase year-over-year.
- Nautilus Biotechnology, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 126.31M shares, a 0.68% increase year-over-year.
- Nautilus Biotechnology, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 126.26M shares, a 0.66% increase from fiscal 2024.
- Nautilus Biotechnology, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 125.43M shares, a 0.41% increase from fiscal 2023.
- Nautilus Biotechnology, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 124.92M shares, a 0.26% increase from fiscal 2022.
- Nautilus Biotechnology, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 124.59M shares, a 47.51% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 127.14M shares 10-Q · filed 2026-07-28 | 126.89M shares 10-Q · filed 2026-07-28 | 126.71M shares derived: average of 3 quarters · filed 2026-07-28 | 126.61M shares derived: average of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | 126.63M shares 10-Q · filed 2026-04-28 | 126.50M shares derived: average of 2 quarters · filed 2026-04-28 | 126.44M shares derived: average of 3 quarters · filed 2026-04-28 | 126.38M shares derived: average of 4 quarters · filed 2026-07-28 |
| 2025-12-31 | 126.37M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 126.34M shares derived: average of 2 quarters · filed 2026-02-26 | 126.29M shares derived: average of 3 quarters · filed 2026-07-28 | 126.26M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 126.31M shares 10-Q · filed 2025-10-28 | 126.25M shares derived: average of 2 quarters · filed 2026-07-28 | 126.22M shares 10-Q · filed 2025-10-28 | 126.11M shares derived: average of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | 126.20M shares 10-Q · filed 2026-07-28 | 126.17M shares 10-Q · filed 2026-07-28 | 126.05M shares derived: average of 3 quarters · filed 2026-07-28 | 125.90M shares derived: average of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | 126.14M shares 10-Q · filed 2026-04-28 | 125.97M shares derived: average of 2 quarters · filed 2026-04-28 | 125.80M shares derived: average of 3 quarters · filed 2026-04-28 | 125.68M shares derived: average of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | 125.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 125.63M shares derived: average of 2 quarters · filed 2026-02-26 | 125.52M shares derived: average of 3 quarters · filed 2026-02-26 | 125.43M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 125.45M shares 10-Q · filed 2025-10-28 | 125.39M shares derived: average of 2 quarters · filed 2025-10-28 | 125.30M shares 10-Q · filed 2025-10-28 | 125.22M shares derived: average of 4 quarters · filed 2025-10-28 |
| 2024-06-30 | 125.32M shares 10-Q · filed 2025-07-31 | 125.23M shares 10-Q · filed 2025-07-31 | 125.15M shares derived: average of 3 quarters · filed 2025-07-31 | 125.09M shares derived: average of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | 125.14M shares 10-Q · filed 2025-04-29 | 125.06M shares derived: average of 2 quarters · filed 2025-04-29 | 125.02M shares derived: average of 3 quarters · filed 2025-04-29 | 124.91M shares derived: average of 4 quarters · filed 2025-04-29 |
| 2023-12-31 | 124.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 124.96M shares derived: average of 2 quarters · filed 2025-02-27 | 124.84M shares derived: average of 3 quarters · filed 2025-02-27 | 124.92M shares 10-K · filed 2025-02-27 |
| 2023-09-30 | 124.93M shares 10-Q · filed 2024-10-29 | 124.77M shares derived: average of 2 quarters · filed 2024-10-29 | 124.90M shares 10-Q · filed 2024-10-29 | 124.73M shares derived: average of 4 quarters · filed 2024-10-29 |
| 2023-06-30 | 124.60M shares 10-Q · filed 2024-07-30 | 124.60M shares 10-Q · filed 2024-07-30 | 124.66M shares derived: average of 3 quarters · filed 2024-07-30 | 124.66M shares derived: average of 4 quarters · filed 2024-07-30 |
| 2023-03-31 | 124.59M shares 10-Q · filed 2024-04-30 | 124.69M shares derived: average of 2 quarters · filed 2024-04-30 | 124.68M shares derived: average of 3 quarters · filed 2024-04-30 | 124.63M shares derived: average of 4 quarters · filed 2024-04-30 |
| 2022-12-31 | 124.79M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 124.72M shares derived: average of 2 quarters · filed 2024-02-28 | 124.65M shares derived: average of 3 quarters · filed 2024-02-28 | 124.59M shares 10-K · filed 2024-02-28 |
| 2022-09-30 | 124.65M shares 10-Q · filed 2023-10-31 | 124.57M shares derived: average of 2 quarters · filed 2023-10-31 | 124.52M shares 10-Q · filed 2023-10-31 | 124.56M shares derived: average of 4 quarters · filed 2023-10-31 |
| 2022-06-30 | 124.49M shares 10-Q · filed 2023-08-02 | 124.46M shares 10-Q · filed 2023-08-02 | 124.53M shares derived: average of 3 quarters · filed 2023-08-02 | 124.42M shares derived: average of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | 124.42M shares 10-Q · filed 2023-05-02 | 124.54M shares derived: average of 2 quarters · filed 2023-05-02 | 124.40M shares derived: average of 3 quarters · filed 2023-05-02 | 107.07M shares derived: average of 4 quarters · filed 2023-05-02 |
| 2021-12-31 | 124.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 124.39M shares derived: average of 2 quarters · filed 2023-02-23 | 101.29M shares derived: average of 3 quarters · filed 2023-02-23 | 84.46M shares 10-K · filed 2023-02-23 |
| 2021-09-30 | 124.11M shares 10-Q · filed 2022-11-01 | 89.59M shares derived: average of 2 quarters · filed 2022-11-01 | 71.06M shares 10-Q · filed 2022-11-01 | 60.98M shares derived: average of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | 55.07M shares 10-Q · filed 2022-08-02 | 44.10M shares 10-Q · filed 2022-08-02 | 39.93M shares derived: average of 3 quarters · filed 2022-08-02 | 37.44M shares derived: average of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | 33.00M shares 10-Q · filed 2022-05-03 | 32.37M shares derived: average of 2 quarters · filed 2022-05-03 | 31.57M shares derived: average of 3 quarters · filed 2022-05-03 | 30.72M shares derived: average of 4 quarters · filed 2022-05-03 |
| 2020-12-31 | 31.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 30.85M shares derived: average of 2 quarters · filed 2022-02-24 | 29.96M shares derived: average of 3 quarters · filed 2022-02-24 | 29.09M shares 10-K · filed 2022-02-24 |
| 2020-09-30 | 29.96M shares 10-Q · filed 2021-11-02 | 29.07M shares derived: average of 2 quarters · filed 2021-11-02 | 28.21M shares 10-Q · filed 2021-11-02 | |
| 2020-06-30 | 28.18M shares 10-Q · filed 2021-08-10 | 27.32M shares 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |